Rankings
▼
Calendar
WGS Q4 2025 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena
WGS
GeneDx Holdings Corp.
$3B
Q4 2025 Earnings
Healthcare
Medical - Healthcare Information Services
Income Statement
Revenue
$121M
+26.5% YoY
Gross Profit
$79M
65.2% margin
Operating Income
-$14M
-11.3% margin
Net Income
-$18M
-14.6% margin
EPS (Diluted)
$-0.59
QoQ Revenue Growth
+3.6%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$7M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$570M
Total Liabilities
$262M
Stockholders' Equity
$308M
Cash & Equivalents
$105M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$121M
$96M
+26.5%
Gross Profit
$79M
$66M
+19.2%
Operating Income
-$14M
$9M
-255.8%
Net Income
-$18M
$5M
-424.9%
Revenue Segments
Diagnostic Test
$118M
49%
Diagnostic Test, Third Party Insurance
$101M
42%
Diagnostic Test, Institutional Customers
$16M
7%
Product and Service, Other
$3M
1%
Diagnostic Test, Self Pay
$297,000
0%
← FY 2025
All Quarters